Research on Nanoparticles and Metal–Organic Framework Structures as Drug Delivery Vehicles

Dear Colleagues,

In recent years, significant advancements have been made in drug delivery, and particularly in the development of nanoparticles and metal–organic frameworks (MOFs). These structures have garnered significant attention in recent years due to their potential to revolutionize drug delivery methods. Nanoparticles, with their small size and large surface area, offer advantages such as enhanced drug solubility, prolonged circulation time, and targeted delivery to specific tissues or cells. Similarly, MOFs, which are a class of crystalline materials composed of metal ions or clusters coordinated to organic ligands, form structures characterized by their porosity and customizable properties and provide unique opportunities for loading and releasing therapeutic agents in a controlled manner. The combination of these innovative materials holds promise for overcoming the challenges associated with traditional drug delivery systems, such as poor bioavailability and off-target effects.

In this Special Issue titled “Research on Nanoparticles and Metal–Organic Framework Structures as Drug Delivery Vehicles”, we aim to highlight recent advances in nanoparticles and MOFs as drug delivery systems.

We invite researchers to submit original research articles and review articles covering various aspects of this topic, including, but not limited to, the synthesis of nanoparticles and metal–organic frameworks, material characterization, in vitro and in vivo studies on their therapeutic efficacy, and clinical trials in the pharmaceutical field. Additionally, we encourage submissions that advance our knowledge on the synthesis, characterization, and therapeutic application of these innovative materials.

We look forward to receiving your contributions.

Prof. Dr. Xianyi Sha
Dr. Rosa Iacobazzi
Dr. Marina Paiva Abuçafy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• metal–organic frameworks (MOFs)
• green synthesis of nanoparticles
• nanotechnology
• synthesis and characterization
• theranostics
• drug delivery kinetics
• targeting drug delivery
• stimuli-responsive nanoparticles
• in vitro and in vivo studies